CRISPR Therapeutics AG
NASDAQ:CRSP
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
CRISPR Therapeutics AG
NASDAQ:CRSP
|
CH |
|
Silvercorp Metals Inc
TSX:SVM
|
CA |
|
Softwareone Holding AG
OTC:SWONF
|
CH |
|
7digital Group plc
LSE:7DIG
|
UK |
|
Equinox Gold Corp
TSX:EQX
|
CA |
|
A
|
ABx Group Ltd
ASX:ABX
|
AU |
|
A
|
Axo Copper Corp
XTSX:AXO
|
CA |
|
Intelligent Wave Inc
TSE:4847
|
JP |
|
A
|
ABC Company SpA Societa Benefit
MIL:ABC
|
IT |
|
Qualisys Holding AB (publ)
F:R0A
|
SE |
|
Schroder BSC Social Impact Trust PLC
LSE:SBSI
|
UK |
|
M
|
MYND Life Sciences Inc
CNSX:MYND
|
CA |
|
ClearStream Energy Services Inc
TSX:CSM
|
CA |
|
Dollarama Inc
TSX:DOL
|
CA |
|
Toronto-Dominion Bank
TSX:TD
|
CA |
|
Self Storage Group ASA
OSE:SSG
|
NO |
|
United Airlines Holdings Inc
NASDAQ:UAL
|
US |
|
Ooedo Onsen Reit Investment Corp
TSE:3472
|
JP |
Wall Street
Price Targets
CRSP Price Targets Summary
CRISPR Therapeutics AG
According to Wall Street analysts, the average 1-year price target for
CRSP
is 84.28 USD
with a low forecast of 33.33 USD and a high forecast of 330.75 USD.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is CRSP's stock price target?
Price Target
84.28
USD
According to Wall Street analysts, the average 1-year price target for
CRSP
is 84.28 USD
with a low forecast of 33.33 USD and a high forecast of 330.75 USD.
What is CRISPR Therapeutics AG's Revenue forecast?
Projected CAGR
463%
For the last 10 years the
compound annual growth rate for
CRISPR Therapeutics AG's revenue is
33%.
The projected
CAGR
for the next 3 years is
463%.
